Literature DB >> 1765980

Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.

H Mielants1, E M Veys, S Goemaere, K Goethals, C Cuvelier, M De Vos.   

Abstract

Ileocolonoscopy was performed on 354 patients with spondyloarthropathies. Histologically, the population could be divided into 145 patients with normal gut histology, 88 patients with acute inflammatory lesions and 121 patients with chronic inflammatory lesions. A number of clinical, biologic, radiologic and genetic variables were determined before ileocolonoscopy. Chronic gut lesions were associated with a family history of ankylosing spondylitis (AS) and Crohn's disease, several episodes of diarrhea, an increased stool frequency, elevated inflammatory serum variables, reduced axial mobility, the presence of sacroiliitis, bamboo spine, destructive joint lesions, a diagnosis of AS and HLA-Bw62 positivity. As the frequency of HLA-Bw62 is also increased in proven Crohn's disease, this would suggest that chronic gut lesions are related to this disease. Acute inflammatory lesions were related to a higher fecal carriage of specific bacteria and to the diagnosis of undifferentiated spondyloarthropathy, especially the enterogenic forms of reactive arthritis. Consequently, these lesions also appear to be related to a bacterially induced gut inflammation. Gut histology was normal in urogenital inflammation and urogenital reactive arthritis, suggesting a different portal of entry for antigens. The 3 histologic pictures of the gut (normal, acute and chronic) inflammation seem to correlate with different clinical, biologic and radiologic manifestations of the disease concept of spondyloarthropathies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1765980

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  39 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

2.  Increased intestinal permeability in ankylosing spondylitis.

Authors:  H Mielants; E M Veys; M De Vos; C Cuvelier
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 3.  The transition of acute to chronic bowel inflammation in spondyloarthritis.

Authors:  Liesbet Van Praet; Peggy Jacques; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

4.  Fecal calprotectin in children with the enthesitis-related arthritis subtype of juvenile idiopathic arthritis.

Authors:  Matthew L Stoll; Marilynn Punaro; Ashish S Patel
Journal:  J Rheumatol       Date:  2011-10       Impact factor: 4.666

5.  TLR4 mutations (Asp299Gly and Thr399Ile) are not associated with ankylosing spondylitis.

Authors:  R Adam; R D Sturrock; J A Gracie
Journal:  Ann Rheum Dis       Date:  2006-08       Impact factor: 19.103

6.  The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms.

Authors:  Jane Zochling; Martin H J Bohl-Bühler; Xenofon Baraliakos; Ernst Feldtkeller; Jürgen Braun
Journal:  Clin Rheumatol       Date:  2005-12-23       Impact factor: 2.980

Review 7.  Juvenile spondyloarthritis.

Authors:  Sabrina Gmuca; Pamela F Weiss
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

Review 8.  Interactions of the innate and adaptive arms of the immune system in the pathogenesis of spondyloarthritis.

Authors:  M L Stoll
Journal:  Clin Exp Rheumatol       Date:  2011-04-19       Impact factor: 4.473

Review 9.  [What rheumatologists can learn from gastroenterologists].

Authors:  S Fischer; C Beyer; M F Neurath
Journal:  Z Rheumatol       Date:  2018-08       Impact factor: 1.372

10.  Management and evaluation of extra-articular manifestations in spondyloarthritis.

Authors:  Irene E van der Horst-Bruinsma; Michael T Nurmohamed
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-12       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.